Loading chart…
PRE-MARKET
Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.
Cohance Lifesciences Limited (COHANCE) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The COHANCE share price is ₹442.00 (-2.02% today), with a market capitalisation of ₹169B and a price-to-earnings (P/E) ratio of 371.4. MarketRipple tracks the COHANCE investment thesis, the ripple-chain impact of market events on Cohance Lifesciences Limited, and the Healthcare sector outlook.
Open
₹415.00
High
₹444.80
Low
₹415.00
Prev. Close
₹451.10
52W High
₹715.00
52W Low
₹266.70
Day range
₹415.00–₹444.80
52-week range
₹266.70–₹715.00
Volume
347K
P/E
371.4
ROE
4.6%
D/E
0.10
Margin
5.0%
Cohance Lifesciences Limited (NSE: COHANCE) is currently trading at ₹442.00 (-2.02%).
Cohance Lifesciences Limited's market capitalization is ₹169B.
Cohance Lifesciences Limited's price-to-earnings (P/E) ratio is 371.4.
Cohance Lifesciences Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Cohance Lifesciences Limited currently reads neutral, based on 10 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.